| Gene symbol | CD19 | Synonyms | B4, CVID3 | Type of gene | protein-coding |
| Chromosome | 16 | Map location | 16p11.2 | dbXrefs | |
| Description | CD19 molecule | ||||
| GTO ID | GTC1883 |
| Trial ID | NCT03497533 |
| Disease | B-Cell Non-Hodgkin's Lymphoma |
| Altered gene | CD19 |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | TriCAR-T CD19 cells |
| Generation | 2nd |
| Phase | Phase1|Phase2 |
| Recruitment status | Unknown |
| Title | Treatment of Refractory/Relapsed Non-Hodgkin Lymphoma With TriCAR-T_CD19 |
| Year | 2018 |
| Country | China |
| Company sponsor | Timmune Biotech Inc. |
| Other ID(s) | ChiCTR1800014528 |
| Cohort 1 | |||||||||||
|
|||||||||||